Pharma Stocks
-
What Recent Specialty Pharma Moves Mean for Cardinal Health’s Stock Valuation
Wondering if Cardinal Health is delivering real value or is just riding a wave? You are not alone, and now…
Read More » -
NRx Pharmaceuticals ANDA for KETAFREE received by FDA
NRx Pharmaceuticals (NASDAQ: NRXP) announced the FDA has received and deemed substantially complete its Abbreviated New Drug Application (ANDA) for…
Read More » -
Sun Pharma Advanced Research Company Surges with Unprecedented Buying Interest
Exceptional Market Activity and Price Movement On 2 December 2025, Sun Pharma Advanced Research Company Ltd (SPARC) demonstrated remarkable market…
Read More » -
NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21
NRx Pharmaceuticals, Inc. WILMINGTON, Del., Dec. 01, 2025 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, the “Company”, “NRx”), a…
Read More » -
Pharma stock with revenue growth guidance of 350% to add to your watchlist
This Pharma stock, is engaged in manufacturing high‑purity pharmaceutical intermediates and active pharmaceutical ingredients used by pharma, nutraceutical, personal care,…
Read More » -
Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Open Interest and Volume Dynamics Recent data reveals that Mankind Pharma’s open interest (OI) in derivatives has expanded by 1,427…
Read More » -
Sun Pharma and 2 other Nifty 500 stocks with golden crossover to keep on your radar
A golden crossover is a widely recognized bullish signal in the stock market, indicating a potential upward trend. It occurs…
Read More » -
A Fresh Look at Ascendis Pharma (ASND) Valuation Following FDA Extension for TransCon CNP Review
Ascendis Pharma (NasdaqGS:ASND) recently shared that the FDA has extended its review timeline for TransCon CNP by three months because…
Read More » -
Amneal Pharmaceuticals, Inc.’s (NASDAQ:AMRX) Price Is Right But Growth Is Lacking After Shares Rocket 25%
Despite an already strong run, Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) shares have been powering on, with a gain of 25% in…
Read More » -
The “pharma reversal”: 2 stocks breaking out for a 2026 rally – Stock Insights News
The Nifty50 gained over 10% year to date vs Nifty Pharma delivered -2.36%, due to global uncertainty around U.S. tariff…
Read More »